PortalPublikationenPruritus assessment in clinical Trials: consensus recommenda...

Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials

Standard

Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. / Ständer, Sonja; Augustin, Matthias; Reich, Adam; Blome, Christine; Ebata, Toshiya; Phan, Ngoc Quan; Szepietowski, Jacek C.

in: ACTA DERM-VENEREOL, Jahrgang 93, Nr. 5, 04.09.2013, S. 509-14.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Ständer, S, Augustin, M, Reich, A, Blome, C, Ebata, T, Phan, NQ & Szepietowski, JC 2013, 'Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials', ACTA DERM-VENEREOL, Jg. 93, Nr. 5, S. 509-14. https://doi.org/10.2340/00015555-1620

APA

Ständer, S., Augustin, M., Reich, A., Blome, C., Ebata, T., Phan, N. Q., & Szepietowski, J. C. (2013). Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. ACTA DERM-VENEREOL, 93(5), 509-14. https://doi.org/10.2340/00015555-1620

Vancouver

Ständer S, Augustin M, Reich A, Blome C, Ebata T, Phan NQ et al. Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials. ACTA DERM-VENEREOL. 2013 Sep 4;93(5):509-14. https://doi.org/10.2340/00015555-1620

Bibtex

@article{4e4e269dd70d4b79ad03c36249449d32,
title = "Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials",
abstract = "Chronic pruritus is a common symptom and there is an urgent need to test new anti-pruritic substances in high-quality clinical trials. However, no widely accepted standardized and validated method for objectively measuring pruritus is yet available. A special interest group of the International Forum for the Study of Itch has been established to assess scoring methods and questionnaires for use in clinical trials. This paper presents our current recommendations. The set of measures we recommend includes pruritus intensity scales, instruments for assessment of scratch lesions, chronic pruritus course, quality of life and patient benefits.",
keywords = "Antipruritics, Chronic Disease, Clinical Trials as Topic, Humans, Predictive Value of Tests, Pruritus, Quality of Life, Questionnaires, Research Design, Severity of Illness Index, Treatment Outcome",
author = "Sonja St{\"a}nder and Matthias Augustin and Adam Reich and Christine Blome and Toshiya Ebata and Phan, {Ngoc Quan} and Szepietowski, {Jacek C}",
year = "2013",
month = sep,
day = "4",
doi = "10.2340/00015555-1620",
language = "English",
volume = "93",
pages = "509--14",
journal = "ACTA DERM-VENEREOL",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato-Venereologica",
number = "5",

}

RIS

TY - JOUR

T1 - Pruritus assessment in clinical Trials: consensus recommendations from the International Forum for the Study of Itch (IFSI) Special Interest Group Scoring Itch in Clinical Trials

AU - Ständer, Sonja

AU - Augustin, Matthias

AU - Reich, Adam

AU - Blome, Christine

AU - Ebata, Toshiya

AU - Phan, Ngoc Quan

AU - Szepietowski, Jacek C

PY - 2013/9/4

Y1 - 2013/9/4

N2 - Chronic pruritus is a common symptom and there is an urgent need to test new anti-pruritic substances in high-quality clinical trials. However, no widely accepted standardized and validated method for objectively measuring pruritus is yet available. A special interest group of the International Forum for the Study of Itch has been established to assess scoring methods and questionnaires for use in clinical trials. This paper presents our current recommendations. The set of measures we recommend includes pruritus intensity scales, instruments for assessment of scratch lesions, chronic pruritus course, quality of life and patient benefits.

AB - Chronic pruritus is a common symptom and there is an urgent need to test new anti-pruritic substances in high-quality clinical trials. However, no widely accepted standardized and validated method for objectively measuring pruritus is yet available. A special interest group of the International Forum for the Study of Itch has been established to assess scoring methods and questionnaires for use in clinical trials. This paper presents our current recommendations. The set of measures we recommend includes pruritus intensity scales, instruments for assessment of scratch lesions, chronic pruritus course, quality of life and patient benefits.

KW - Antipruritics

KW - Chronic Disease

KW - Clinical Trials as Topic

KW - Humans

KW - Predictive Value of Tests

KW - Pruritus

KW - Quality of Life

KW - Questionnaires

KW - Research Design

KW - Severity of Illness Index

KW - Treatment Outcome

U2 - 10.2340/00015555-1620

DO - 10.2340/00015555-1620

M3 - SCORING: Journal article

C2 - 23624777

VL - 93

SP - 509

EP - 514

JO - ACTA DERM-VENEREOL

JF - ACTA DERM-VENEREOL

SN - 0001-5555

IS - 5

ER -